Related Experiment Video
Updated: Jul 17, 2026

Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology
Published on: March 14, 2020
Pathology of the liver
1College of Physicians and Surgeons of Columbia University, New York, New York 10032, USA. jhl3@columbia.edu
This year in liver pathology, new molecular techniques detect hepatitis C virus recurrence early post-transplant. Research also detailed chronic rejection markers and drug-induced liver injury, including troglitazone risks.
Area of Science:
- Hepatology and Transplant Pathology
- Molecular Diagnostics in Infectious Diseases
Background:
- Liver pathology advancements integrate traditional and molecular approaches.
- Hepatitis C virus (HCV) infection and its sequelae remain a significant focus.
- Drug-induced liver injury (DILI) necessitates ongoing surveillance.
Purpose of the Study:
- To summarize key findings in liver pathology from recent studies.
- To highlight advancements in diagnosing HCV recurrence and chronic rejection.
- To document emerging associations and adverse drug reactions.
Main Methods:
- Review of traditional anatomic pathology findings.
- Application of molecular techniques like reverse transcription polymerase chain reaction (RT-PCR).
- Analysis of clinical data and case reports on drug toxicity.
Main Results:
- RT-PCR identifies hepatitis C virus recurrence within 5 days post-transplant.
- Chronic rejection characterized by ductopenia and hepatic artery loss.
- Troglitazone linked to severe bridging and submassive necrosis.
- HCV infection associated with lymphoproliferative diseases and cholangiocarcinoma.
Conclusions:
- Molecular methods enhance early detection of viral recurrence.
- Understanding chronic rejection mechanisms is crucial for transplant outcomes.
- Pharmacovigilance is essential for identifying and mitigating DILI.
- New associations between HCV and malignancies warrant further investigation.
Related Concept Videos
Liver Histology
Hepatocytes perform a variety of essential functions. They secrete...
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can also...
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Cirrhosis I: Introduction
Cirrhosis II: Pathophysiology

